164 related articles for article (PubMed ID: 9689425)
41. A new class of leukotriene biosynthesis inhibitor: the development of MK-0591.
Prasit P; Belley M; Blouin M; Brideau C; Chan C; Charleson S; Evans JF; Frenette R; Gauthier JY; Guay J
J Lipid Mediat; 1993; 6(1-3):239-44. PubMed ID: 8357985
[TBL] [Abstract][Full Text] [Related]
42. Anticomplementary activity of boswellic acids--an inhibitor of C3-convertase of the classical complement pathway.
Kapil A; Moza N
Int J Immunopharmacol; 1992 Oct; 14(7):1139-43. PubMed ID: 1452399
[TBL] [Abstract][Full Text] [Related]
43. Effect of Pygeum africanum extract on A23187-stimulated production of lipoxygenase metabolites from human polymorphonuclear cells.
Paubert-Braquet M; Cave A; Hocquemiller R; Delacroix D; Dupont C; Hedef N; Borgeat P
J Lipid Mediat Cell Signal; 1994 May; 9(3):285-90. PubMed ID: 7921787
[TBL] [Abstract][Full Text] [Related]
44. Boswellic acids: A leukotriene inhibitor also effective through topical application in inflammatory disorders.
Singh S; Khajuria A; Taneja SC; Johri RK; Singh J; Qazi GN
Phytomedicine; 2008 Jun; 15(6-7):400-7. PubMed ID: 18222672
[TBL] [Abstract][Full Text] [Related]
45. Concentration-dependent potentiating and inhibitory effects of Boswellia extracts on 5-lipoxygenase product formation in stimulated PMNL.
Safayhi H; Boden SE; Schweizer S; Ammon HP
Planta Med; 2000 Mar; 66(2):110-3. PubMed ID: 10763581
[TBL] [Abstract][Full Text] [Related]
46. Fuscoside: an anti-inflammatory marine natural product which selectively inhibits 5-lipoxygenase. Part II: Biochemical studies in the human neutrophil.
Jacobson PB; Jacobs RS
J Pharmacol Exp Ther; 1992 Aug; 262(2):874-82. PubMed ID: 1323665
[TBL] [Abstract][Full Text] [Related]
47. Suppression of experimental autoimmune encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibition.
Prosiegel M; Neu I; Mallinger J; Wildfeuer A; Mehlber L; Vogl S; Hoffmann G; Ruhenstroth-Bauer G
Acta Neurol Scand; 1989 Mar; 79(3):223-6. PubMed ID: 2541593
[TBL] [Abstract][Full Text] [Related]
48. Characterization of 3alpha-acetyl-11-keto-alpha-boswellic acid, a pentacyclic triterpenoid inducing apoptosis in vitro and in vivo.
Büchele B; Zugmaier W; Estrada A; Genze F; Syrovets T; Paetz C; Schneider B; Simmet T
Planta Med; 2006 Nov; 72(14):1285-9. PubMed ID: 17022003
[TBL] [Abstract][Full Text] [Related]
49. Frankincense--therapeutic properties.
Al-Yasiry AR; Kiczorowska B
Postepy Hig Med Dosw (Online); 2016 Jan; 70():380-91. PubMed ID: 27117114
[TBL] [Abstract][Full Text] [Related]
50. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400
[TBL] [Abstract][Full Text] [Related]
51. Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly.
Gomaa AA; Mohamed HS; Abd-Ellatief RB; Gomaa MA
Inflammopharmacology; 2021 Aug; 29(4):1033-1048. PubMed ID: 34224069
[TBL] [Abstract][Full Text] [Related]
52. [Leukotriene synthesis by gastrointestinal tissue and its pharmacologic modification].
Peskar BM; Kozuschek W; Morgenroth K; Hoppe U; Dreyling KW; Peskar BA
Wien Klin Wochenschr; 1986 Feb; 98(4):98-104. PubMed ID: 3010577
[TBL] [Abstract][Full Text] [Related]
53. High-performance thin layer chromatographic analysis of anti-inflammatory triterpenoids from Boswellia serrata Roxb.
Krohn K; Rao MS; Raman NV; Khalilullah M
Phytochem Anal; 2001; 12(6):374-6. PubMed ID: 11793815
[TBL] [Abstract][Full Text] [Related]
54. Pharmacological characterization of WAY-121,520: a potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2).
Glaser KB; Carlson RP; Sung A; Bauer J; Lock YW; Holloway D; Sturm R; Hartman D; Walter T; Woeppel S
Agents Actions; 1993; 39 Spec No():C30-2. PubMed ID: 8273577
[TBL] [Abstract][Full Text] [Related]
55. Triterpene Acids from Frankincense and Semi-Synthetic Derivatives That Inhibit 5-Lipoxygenase and Cathepsin G.
Koeberle A; Henkel A; Verhoff M; Tausch L; König S; Fischer D; Kather N; Seitz S; Paul M; Jauch J; Werz O
Molecules; 2018 Feb; 23(2):. PubMed ID: 29495286
[TBL] [Abstract][Full Text] [Related]
56. Inhibitory effects of lignans and flavonoids in saiboku-to, a herbal medicine for bronchial asthma, on the release of leukotrienes from human polymorphonuclear leukocytes.
Homma M; Minami M; Taniguchi C; Oka K; Morita S; Niitsuma T; Hayashi T
Planta Med; 2000 Feb; 66(1):88-91. PubMed ID: 10705748
[TBL] [Abstract][Full Text] [Related]
57. In vitro metabolism, permeation, and brain availability of six major boswellic acids from Boswellia serrata gum resins.
Gerbeth K; Hüsch J; Fricker G; Werz O; Schubert-Zsilavecz M; Abdel-Tawab M
Fitoterapia; 2013 Jan; 84():99-106. PubMed ID: 23103296
[TBL] [Abstract][Full Text] [Related]
58. Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation.
Marshall LA; Winkler JD; Griswold DE; Bolognese B; Roshak A; Sung CM; Webb EF; Jacobs R
J Pharmacol Exp Ther; 1994 Feb; 268(2):709-17. PubMed ID: 8113982
[TBL] [Abstract][Full Text] [Related]
59. 5-Lipoxygenase inhibitory and antihistamine activities of linetastine.
Shizawa T; Ohmori S; Maeda K; Sakata K; Ishii T; Kamitani T
Arzneimittelforschung; 1996 Nov; 46(11):1072-6. PubMed ID: 8955867
[TBL] [Abstract][Full Text] [Related]
60. Characterization of an acetyl-11-keto-beta-boswellic acid and arachidonate-binding regulatory site of 5-lipoxygenase using photoaffinity labeling.
Sailer ER; Schweizer S; Boden SE; Ammon HP; Safayhi H
Eur J Biochem; 1998 Sep; 256(2):364-8. PubMed ID: 9760176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
